{
    "physical_examinations": [
        {
            "date": "Not specified",
            "vital_signs": {
                "blood_glucose": "31 mg/dl (1.7 mmol/liter)",
                "insulin_level": "172 mU/liter",
                "weight": "4460 g",
                "length": "54 cm"
            },
            "relevant_findings": {
                "type": "Severe hypoglycemia",
                "diagnosis": "Congenital hyperinsulinism",
                "treatment": "Intravenous glucose and diazoxide"
            },
            "changes_over_time": "Despite treatment with diazoxide, the patient continued to have severe hypoglycemic episodes, leading to further medical interventions including octreotide and nifedipine."
        },
        {
            "date": "4 months",
            "vital_signs": {
                "insulin_levels_after_catheterization": "(Unspecific Value)"
            },
            "relevant_findings": {
                "type": "Biventricular hypertrophy",
                "examination": "Cardiac ultrasound"
            },
            "changes_over_time": "Biventricular hypertrophy was noted at 4 months prior to the subtotal pancreatectomy at 5 months."
        },
        {
            "date": "5 months",
            "vital_signs": "Not specified",
            "relevant_findings": {
                "surgical_procedure": "Subtotal pancreactectomy (95%)",
                "post_op_condition": "Developed diabetes"
            },
            "changes_over_time": "After the surgery, insulin treatment was initiated."
        },
        {
            "date": "20 months",
            "vital_signs": {
                "daily_insulin_dose": "0.54 U/kg",
                "HbA1c": "6.9%"
            },
            "relevant_findings": {
                "medical_condition": "Diabetes management",
                "glucose_levels": "Maximum levels of 181 mg/dl (10 mmol/liter)"
            },
            "changes_over_time": "The insulin dose was gradually tapered."
        },
        {
            "date": "23 months",
            "vital_signs": "Not specified",
            "relevant_findings": {
                "insulin_management": "Stopped"
            },
            "changes_over_time": "Insulin treatment was completely stopped with stable blood glucose levels."
        },
        {
            "date": "36 months",
            "vital_signs": {
                "HbA1c": "5.4%"
            },
            "relevant_findings": {
                "condition": "No hypoglycemic episodes"
            },
            "changes_over_time": "HbA1c values decreased to 5.4% without treatment."
        }
    ]
}